Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

Objective: To investigate possible mechanistic factors to explain cefiderocol (CFDC) non-susceptibility, we characterized 38 clinical isolates with a CFDC minimum inhibitory concentration (MIC) of >4 μg/mL from a multi-national surveillance study. Methods: The MIC measurement in the presence of β-la...

Descripció completa

Dades bibliogràfiques

Autors principals:	Naoki Kohira, Meredith A. Hackel, Yoshino Ishioka, Miho Kuroiwa, Daniel F. Sahm, Takafumi Sato, Hideki Maki, Yoshinori Yamano
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2020-09-01
Col·lecció:	Journal of Global Antimicrobial Resistance
Matèries:	Cefiderocol Siderophore cephalosporin Gram-negative bacilli PER-type β-lactamase Cefiderocol non-susceptible
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2213716520301843
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!